Michael Pishvaian
0000-0002-1165-9041
2 papers found
Refreshing results…
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria
Missing publications? Search for publications with a matching author name.